Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry.

Wanying XiaYuling QianYangyi LinRui-Lin QuanYuanhua YangZhenwen YangHongyan TianShengqing LiJieyan ShenYingqun JiQing GuHuijun HanChangming XiongJian-Guo He

Published in: Respirology (Carlton, Vic.) (2024)

Off-label targeted drugs contributed to improved long-term survival in CTEPH patients receiving pharmacotherapies.

Keyphrases

pulmonary hypertension
cancer therapy
clinical trial
quality improvement
pulmonary artery
drug induced
atrial fibrillation
study protocol
pulmonary arterial hypertension
randomized controlled trial
cross sectional